Safety of Janus Kinase Inhibitors in Patients With Inflammatory Bowel Diseases or Other Immune-mediated Diseases: A Systematic Review and Meta-Analysis
Pablo A. Olivera, Juan S. Lasa, Stefanos Bonovas, Silvio Danese, Laurent Peyrin‐Biroulet
Topics & Concepts
MedicineTofacitinibInternal medicineJanus kinase inhibitorIncidence (geometry)Ankylosing spondylitisAdverse effectUlcerative colitisMeta-analysisRandomized controlled trialPsoriatic arthritisRheumatoid arthritisOpticsDiseasePhysicsCytokine Signaling Pathways and InteractionsPsoriasis: Treatment and PathogenesisInflammatory Bowel Disease